As of 2024-12-15, the Relative Valuation of Scandion Oncology A/S (SCOL.ST) is 0.09 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 SEK, the upside of Scandion Oncology A/S based on Relative Valuation is 5.6%.
The range of the Relative Valuation is 0.09 - 0.09 SEK.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -0.4x - -0.4x | -0.4x |
| Fair Price | 0.09 - 0.09 | 0.09 |
| Upside | 5.6% - 5.6% | 5.6% |
| Date | P/E |
| 2024-10-24 | -0.52 |
| 2024-10-23 | -0.52 |
| 2024-10-22 | -0.54 |
| 2024-10-21 | -0.55 |
| 2024-10-18 | -0.55 |
| 2024-10-17 | -0.56 |
| 2024-10-16 | -0.59 |
| 2024-10-15 | -0.56 |
| 2024-10-14 | -0.56 |
| 2024-10-11 | -0.57 |
| 2024-10-10 | -0.58 |
| 2024-10-09 | -0.59 |
| 2024-10-08 | -0.57 |
| 2024-10-07 | -0.58 |
| 2024-10-04 | -0.58 |
| 2024-10-03 | -0.59 |
| 2024-10-02 | -0.61 |
| 2024-10-01 | -0.62 |
| 2024-09-30 | -0.62 |
| 2024-09-27 | -0.65 |
| 2024-09-26 | -0.63 |
| 2024-09-25 | -0.61 |
| 2024-09-24 | -0.59 |
| 2024-09-23 | -0.61 |
| 2024-09-20 | -0.62 |
| 2024-09-19 | -0.61 |
| 2024-09-18 | -0.58 |
| 2024-09-17 | -0.54 |
| 2024-09-16 | -0.55 |
| 2024-09-13 | -0.55 |
| 2024-09-12 | -0.60 |
| 2024-09-11 | -0.62 |
| 2024-09-10 | -0.62 |
| 2024-09-09 | -0.63 |
| 2024-09-06 | -0.64 |
| 2024-09-05 | -0.61 |
| 2024-09-04 | -0.62 |
| 2024-09-03 | -0.64 |
| 2024-09-02 | -0.63 |
| 2024-08-30 | -0.65 |
| 2024-08-29 | -0.68 |
| 2024-08-28 | -0.66 |
| 2024-08-27 | -0.66 |
| 2024-08-26 | -0.66 |
| 2024-08-23 | -0.69 |
| 2024-08-22 | -0.70 |
| 2024-08-21 | -0.68 |
| 2024-08-20 | -0.72 |
| 2024-08-19 | -0.76 |
| 2024-08-16 | -0.67 |